Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001093347 | SCV001250282 | likely benign | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001255550 | SCV001432020 | likely benign | not specified | 2020-08-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001418265 | SCV001620490 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-07-10 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV001255550 | SCV002073469 | likely benign | not specified | 2022-01-16 | criteria provided, single submitter | clinical testing | This synonymous variant has occurred in GnomAD with a total MAF of 0.0012% and with the highest MAF of 0.0033% in the South Asian population. This position is not conserved. In silico splicing algorithm predicted no impact on splicing, but no functional studies were performed to confirm this prediction. This variant NM_002230.4(JUP):c.1506C>T (p.Ile502=) is present in the ClinVar database (ID: 872721). The variant has not occurred in the literature in association with the disease. Considering that the variant has a relatively high frequency in a subpopulation, it has been classified as Likely Benign. |
Ambry Genetics | RCV002393353 | SCV002699441 | likely benign | Cardiovascular phenotype | 2019-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |